After in vitro expansion, tumor-reactive TILs have a greater percentage of PD-1-expressing CD8 + T cells, which produce much higher tumor-specific IFN-γ compared with the PD-1-negative counterparts [109]. Here, PDCD1 is linked to neoplasm.